Adagio Medical Holdings, Inc. (ADGM)

Market Cap	27.38M
Revenue (ttm)	602,000
Net Income (ttm)	-75.04M
Shares Out	15.38M
EPS (ttm)	-11.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	115,479,189
Open	0.980
Previous Close	0.923
Day's Range	0.970 - 2.860
52-Week Range	0.625 - 9.340
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2025

About ADGM

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio M...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 80
• Stock Exchange: NASDAQ
• Ticker Symbol: ADGM
• Website: https://adagiomedical.com

Financial Performance

In 2024, Adagio Medical Holdings's revenue was $602,000, an increase of 100.67% compared to the previous year's $300,000. Losses were -$75.04 million, 105.1% more than in 2023.

Financial numbers in USD